The Opportunity The Genentech Executive Communications team, within Corporate Communications, is seeking.... This role plays a critical part in advancing Genentech’s long-term business strategy while reinforcing our culture, values...
benefits. Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat...
we love. That’s what makes us Genentech, a member of the Roche Group! The Opportunity We are seeking a highly motivated... also qualifies for the benefits detailed at the link provided below. Genentech is an equal opportunity employer. It is our policy...
benefits detailed at the link provided below. Benefits #PPDT #PDDSSF Genentech is an equal opportunity employer. It...
we love. That’s what makes us Genentech! The Opportunity The Global Head of Analytical Development and Quality Control... below. Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat...
for the benefits detailed at the link provided below: #PDC2026 ​ Genentech is an equal opportunity employer. It...
. The Opportunity The Senior Learning Business Partner (LBP) is a key leadership role at Genentech, serving as a trusted... and delivery The role requires an onsite presence at our South San Francisco Genentech Campus;Relocation assistance...
Title: Head of Commercial, Medical and Government (CMG) Affairs Strategy & Activation and Chief of Staff To Genentech... change and execute high-priority, cross-functional projects on behalf of the CEO within Genentech and globally within Roche...
Join Genentech’s Security, Safety, Health and Environment Team as an Industrial Hygiene Program Manager! Unleash... and safety in the workplace? Genentech is looking for an exceptional individual to manage industrial hygiene programs...
(ECD) department at Roche/Genentech. In this role, you will contribute to the development of innovative software solutions... across workflows in Clinical Trial Development. Innovation: Following AI/Software developments at Roche/Genentech to identify new...